Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
We performed a prospective, randomized, multicenter trial to assess the efficacy and safety
of combined treatment with mitiglinide and metformin for patients with type 2 diabetes who
show inadequate glycemic control with metformin monotherapy. Subjects with HbA1c >7.0% after
an 8-week metformin run-in phase were randomized to a 16-week trial phase with metformin plus
mitiglinide (Met+Mit) or metformin plus placebo (Met).
Phase:
Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Chonbuk National University Chonnam National University Chungnam National University Eulji University Hallym University Korea University Kyungpook National University Kyungpook National University Hospital Pusan National University College of Medicine Seoul St. Mary's Hospital Sungkyunkwan University The Catholic University of Korea Uijeongbu St. Mary Hospital Yonsei University